APELLIS PHARMACEUTICALS INC filings

SEC filings by APELLIS PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14Avoro Capital Advisors LLCApellis Pharmaceuticals, Inc.13,411,1119.9%EDGAR
SC 13G/A2024-02-14EcoR1 Capital, LLCApellis Pharmaceuticals, Inc.11,173,0689.4%EDGAR
SC 13G2024-02-14T. Rowe Price Investment Management, Inc.Apellis Pharmaceuticals, Inc.6,303,5845.3%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCApellis Pharmaceuticals, Inc.9,555,6788.1%EDGAR
SC 13G/A2024-02-08WELLINGTON MANAGEMENT GROUP LLPApellis Pharmaceuticals, Inc.16,477,85013.9%EDGAR
SC 13G/A2023-09-08WELLINGTON MANAGEMENT GROUP LLPApellis Pharmaceuticals, Inc.14,770,85912.6%EDGAR
SC 13G2023-07-18EcoR1 Capital, LLCApellis Pharmaceuticals, Inc.6,307,5475.4%EDGAR
SC 13G/A2023-07-07BlackRock Inc.Apellis Pharmaceuticals, Inc.5,747,1844.9%EDGAR
SC 13G/A2023-02-14PRICE T ROWE ASSOCIATES INC /MD/Apellis Pharmaceuticals, Inc.2,749,5422.5%EDGAR
SC 13G/A2023-02-14Avoro Capital Advisors LLCApellis Pharmaceuticals, Inc.10,625,0009.6%EDGAR
SC 13G2023-02-14T. Rowe Price Investment Management, Inc.Apellis Pharmaceuticals, Inc.5,842,6605.3%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCApellis Pharmaceuticals, Inc.9,212,4918.3%EDGAR
SC 13G/A2023-02-06WELLINGTON MANAGEMENT GROUP LLPApellis Pharmaceuticals, Inc.8,820,3988.0%EDGAR
SC 13G/A2023-02-01BlackRock Inc.Apellis Pharmaceuticals, Inc.7,704,1947.0%EDGAR
SC 13G/A2022-02-14HHLR ADVISORS, LTD.Apellis Pharmaceuticals, Inc.-0.0%EDGAR
SC 13G/A2022-02-14Morningside Venture Investments LtdApellis Pharmaceuticals, Inc.12,806,34213.2%EDGAR
SC 13G2022-02-14PRICE T ROWE ASSOCIATES INC /MD/Apellis Pharmaceuticals, Inc.5,307,4865.4%EDGAR
SC 13G2022-02-11Avoro Capital Advisors LLCApellis Pharmaceuticals, Inc.8,555,5558.9%EDGAR
SC 13G/A2022-02-09VANGUARD GROUP INCApellis Pharmaceuticals, Inc.7,917,0998.1%EDGAR
SC 13G/A2022-02-04WELLINGTON MANAGEMENT GROUP LLPApellis Pharmaceuticals, Inc.12,478,25312.8%EDGAR